Home › Immune System and Disorders › Connecticut
Immune System and Disorders clinical trials in Connecticut
3 studies for Immune System and Disorders are looking for participants at sites in Connecticut.
Cities in Connecticut
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven
RecruitingObservational study
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
- Yale School of Medicine, New Haven
RecruitingPhase 1/2
1 Day – 21 Years · All sexes · Updated May 29, 2026 · NCT03128996A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Yale University, New Haven
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 29, 2026 · NCT04422912From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.